-
-
-
-
-
-
-
Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda
-
-
-
-
-
-
-
10 policies if Trump wins and stock implications: Jefferies
-
-
-
-
-
-
-
Eli Lilly priced to perfection, Merck the top pharma pick at Jefferies
-
-
-
-
-
-
-
Berkshire's bet a bright spot in gloomy year for Big Pharma stocks
-
-
-
-
-
-
-
Keytruda sales power Merck to quarterly beat
-
-
-
-
-
-
-
Merck (MRK) PT Raised to $52 at Jefferies
-
-
-
-
-
-
-
AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes
-
73,338 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

